Reconfigurable and robust topological edge states in photonic crystals
Optics Express · 18.05.2026 · 34 (10) · 18751
DOI: 10.1364/oe.592445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics Express, online erschienen am 13.05.2026. Verfasst von Muhammad Siraj und 2 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Gefördert von: The Key Project of Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
We present a geometrically reconfigurable photonic crystal platform that sustains robust topological edge transport under large radial perturbations. The system is based on a hexagonal dielectric lattice composed of Ta 2 O 5 pillars, where a sublattice-selective radius modulation induces a controlled transition between trivial and nontrivial Γ-point topological phases through Mie-resonance p – d band inversion. By systematically varying the pillar radii, we demonstrate that the topological edge states remain stable over a broad perturbation range of up to ±6%. Full-wave simulations confirm robust edge localization and waveguiding across complex geometries. The proposed approach establishes radial geometry reconfiguration as an effective strategy for realizing perturbation-invariant topological photonic waveguides, offering a practical route toward fabrication-tolerant and reconfigurable photonic integrated devices.
Förderung
- The Key Project of Science Foundation of Jiangsu Province
Zitieren
APA
Siraj, M., Sheng, T., & Yu, Y. (2026). Reconfigurable and robust topological edge states in photonic crystals. Optics Express, 34(10), 18751. https://doi.org/10.1364/oe.592445
Vancouver
Siraj M, Sheng T, Yu Y. Reconfigurable and robust topological edge states in photonic crystals. Optics Express. 2026;34(10):18751. doi:10.1364/oe.592445
BibTeX
@article{Siraj2026,
author = {Siraj, Muhammad and Sheng, Tianyao and Yu, Yefeng},
title = {Reconfigurable and robust topological edge states in photonic crystals},
journal = {Optics Express},
year = {2026},
volume = {34},
number = {10},
pages = {18751},
doi = {10.1364/oe.592445}
}
EUVIMED